epithalamin is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-11-03. Numbers and descriptions here follow the published literature rather than marketing material.
（TG:@pojiaai）Epitalon is a synthetic linear tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. It emerged from work on epithalamin, a peptide fraction prepared from bovine pineal tissue, and was designed as a short, chemically defined analogue of that extract. Early publications came mainly from Russian laboratories studying pineal peptides and aging-related endpoints. The compound appears in the literature under several spellings, including epithalon and epithalone, which complicates systematic searching. Its small size makes solid-phase assembly and routine analytical characterization straightforward.
Chemically, the molecule consists of four amino acid residues joined by three peptide bonds, with a free N-terminal amino group and a free C-terminal carboxyl group. Its molecular formula is C14H22N4O9, and its monoisotopic mass is approximately 390 daltons. The acidic glutamate and aspartate side chains give the peptide a net negative charge near neutral pH, a property that shapes its chromatographic behaviour and solubility profile. No disulfide bridges or other post-translational modifications are present, so the primary sequence alone defines the structure.
Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.
Several names circulate for the same molecule, including epitalon, epithalone, epithalamin tetrapeptide, and the sequence code AEDG. A CAS registry number, 307297-39-8, is commonly cited for it, though catalogue entries should be checked against supplier documentation because mislabelled records occur. In its usual form the peptide carries free amino and carboxyl termini and is neither glycosylated nor lipidated. Researchers distinguish the defined tetrapeptide from epithalamin itself, a crude pineal preparation containing many peptides that is not chemically characterised.
Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Linear tetrapeptide | Four residues joined by three peptide bonds |
| Sequence | Ala-Glu-Asp-Gly | Commonly abbreviated AEDG |
| Molecular formula | C14H22N4O9 | Free acid form |
| Monoisotopic mass | Approximately 390 Da | Matches values reported from mass spectrometry |
| Net charge near neutral pH | Negative | Contributed by glutamate and aspartate side chains |
Epitalon is the common name for a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, usually abbreviated AEDG. All four residues are proteinogenic amino acids, and the free peptide has a calculated mass near 390 grams per mole. Because the chain is short and carries no modifications, it is assembled readily by solid-phase synthesis and is distributed mainly as a freeze-dried solid for laboratory work. Catalogue listings use the spellings epitalon, epithalone, and simply AEDG, and the three refer to the same sequence.
The compound is generally presented as a synthetic fragment of epithalamin, a pineal gland extract investigated in the former Soviet Union from the 1970s onward. Vladimir Khavinson and colleagues in Saint Petersburg developed short peptides modelled on such extracts, and epitalon became the most widely cited of those sequences. Most primary reports appeared in Russian-language journals or in proceedings with limited international circulation. Independent replication in laboratories outside that network remains sparse, and much repeated secondary material traces back to a small number of originating groups.
Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.
Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.
Epitalon is a synthetic tetrapeptide whose sequence is alanine-glutamate-aspartate-glycine, written in single-letter code as AEDG. The four residues are joined by three peptide bonds, giving a linear backbone with no branching and no disulfide bridges. Its calculated molecular mass for the free form is approximately 390.3 daltons, a figure that rises when the compound is supplied as an acetate or trifluoroacetate salt. Because the chain is short, the molecule is defined entirely by its residue order rather than by any folded three-dimensional structure.
The compound is described in the literature as a derivative of epithalamin, a preparation obtained from bovine pineal tissue. Work on this peptide family was carried out mainly by a research group in Saint Petersburg beginning in the 1980s, and the substance was later registered for clinical use in Russia under the name Epitalon. Outside that region it is generally treated as a research chemical rather than an approved medicine. Statements about its biological activity rest on a relatively small number of studies, and independent replication remains limited.
Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.
Literature searches for this compound must account for several spelling variants. Indexing databases contain epitalon, epithalon, epithalone, and AEDG, and relevant records are scattered across Russian-language and English-language journals that do not consistently cross-cite. Early publications describe the parent extract as a mixture of many peptides, whereas later work addresses the single synthetic tetrapeptide. That shift in nomenclature complicates comparison between studies, because extract data and tetrapeptide data are sometimes cited interchangeably. A search strategy omitting the alternate spellings will return an incomplete set of references.
== Clinical studies == Randomized trials have evaluated Dexcom systems as part of real-time CGM-based diabetes management. In the 2020 MILLENNIALS crossover trial, participants aged 16–24 years with type 1 diabetes used the Dexcom G6 for eight weeks and conventional self-monitoring of blood glucose for eight weeks. During G6 use, the mean percentage of time in the target glucose range of 70–180 mg/dL was 35.7%, compared with 24.6% during self-monitoring, and mean glycated hemoglobin (HbA1c) was 0.76 percentage points lower. The 2021 MOBILE trial randomly assigned 175 adults with poorly controlled type 2 diabetes, treated with basal insulin but not mealtime insulin, to use either the G6 or a conventional blood glucose meter for eight months. HbA1c decreased by 1.1 percentage points in the G6 group and by 0.6 points in the meter group; after adjustment, the between-group difference was 0.4 percentage points. Mean time in the 70–180 mg/dL range was 59% with the G6 and 43% with meter monitoring, while one participant in each group experienced severe hypoglycemia. The study and devices were funded by Dexcom, and a Dexcom employee was among the authors. Both trials compared a CGM-enabled management strategy with fingerstick-based monitoring; they did not compare the G6 with another CGM system.
However, acetals, including those found in polysaccharide linkages, cannot easily become free aldehydes. Reducing sugars react with amino acids in the Maillard reaction, a series of reactions that occurs while cooking food at high temperatures and that is important in determining the flavor of food. Also, the levels of reducing sugars in wine, juice, and sugarcane are indicative of the quality of these food products.
=== Mechanical properties === The reduced vacancy concentration in nanocrystals can negatively affect the motion of dislocations, since dislocation climb requires vacancy migration. In addition, there exists a very high internal pressure due to the surface stress present in small nanoparticles with high radii of curvature. This causes a lattice strain that is inversely proportional to the size of the particle, also well known to impede dislocation motion, in the same way as it does in the work hardening of materials. For example, gold nanoparticles are significantly harder than the bulk material. Furthermore, the high surface-to-volume ratio in nanoparticles makes dislocations more likely to interact with the particle surface. In particular, this affects the nature of the dislocation source and allows the dislocations to escape the particle before they can multiply, reducing the dislocation density and thus the extent of plastic deformation. There are unique challenges associated with the measurement of mechanical properties on the nanoscale, as conventional means such as the universal testing machine cannot be employed. As a result, new techniques such as nanoindentation have been developed that complement existing electron microscope and scanning probe methods. Atomic force microscopy (AFM) can be used to perform nanoindentation to measure hardness, elastic modulus, and adhesion between nanoparticle and substrate. The particle deformation can be measured by the deflection of the cantilever tip over the sample.
Sources: en.wikipedia.org
coding strand Also sense strand, positive (+) sense strand, and nontemplate strand. The strand of a double-stranded DNA molecule whose nucleotide sequence corresponds directly to that of the RNA transcript produced during transcription (except that thymine bases are substituted with uracil bases in the RNA molecule). Though it is not itself transcribed, the coding strand is by convention the strand used when displaying a DNA sequence because of the direct analogy between its sequence and the codons of the RNA product. Contrast template strand; see also sense.
It launched in 1990 by the Brazilian Workers' Party in São Paulo, after the Workers' Party approached other parties and social movements of Latin America and the Caribbean with the objective of debating the new international scenario after the fall of the Berlin Wall and the consequences of the implementation of what were taken as neoliberal policies adopted at the time by contemporary right-leaning governments in the region, with the stated main objective of the conference being to argue for genuine alternatives to neoliberalism. Among its members, it includes democratic socialist and social democratic parties in the region such as Bolivia's Movement for Socialism, Brazil's Workers' Party, the Ecuadorian PAIS Alliance, the Venezuelan United Socialist Party of Venezuela, the Socialist Party of Chile, the Uruguayan Broad Front, the Nicaraguan Sandinista National Liberation Front and the Salvadoran Farabundo Martí National Liberation Front. Former members included the Brazilian Socialist Party and the Popular Socialist Party. In Venezuela, Hugo Chávez was re-elected in October 2012 for his third six-year term as president, but he suddenly died in March 2013 from advanced cancer. After Chávez's death, Nicolás Maduro, the Vice President of the United Socialist Party of Venezuela (PSUV), assumed the powers and responsibilities of the president on 5 March 2013. A special presidential election was held the following which Maduro won by a tight margin as the PSUV's candidate. He was formally inaugurated on 19 April 2013.
Etymology The term poultice comes from the Latin puls or pultēs, meaning "porridge" or "thick pap," through Middle English pultes. This reflects the traditional preparation of poultices as soft, moist masses resembling porridge. Ancient use Poultices have been documented in many ancient medical traditions, including Egypt, Mesopotamia, India, Greece, and Rome. They were usually made from plants, animal products, or minerals, and applied directly to the skin to reduce pain, inflammation, or infection.
Sources: en.wikipedia.org
Balance of power systems have in the past tended, through the process of conquest of lesser states by greater states, towards reduction in the number of states involved, and towards less frequent but more devastating wars, until eventually a universal empire has been established through the conquest by one of all those remaining. The post-Cold War period represents an anomaly to the balance of power theory too. Rousseau defined the theoretical limit how far balance of power can be altered: "Will it be supposed that two or three potentates might enter into an agreement to subdue the rest? Be it so. These three potentates, whoever they may be, will not possess half the power of all Europe." In 2009, Stephen Walt observed, "Within two-and-a-half centuries, only one potentate possessed half the power of all the world, including Europe. In 2008, US military expenditures, including supplemental spending, exceeded those of the rest of the world combined." Since 2000, the founder of Neorealism, Kenneth Waltz, confessed that "the present condition of international politics is unnatural." "Clearly something has changed." Wohlforth, Little and Kaufman undertook the above-mentioned historical study after they had coped with what they called the "puzzle" of the unipolar stability. Elsewhere, Richard Little wrote: Events since the end of the Cold War "create a potential anomaly" for the theory because the outcome has "left the United States as the sole superpower in a unipolar world ... A major puzzle for realists ...
== Further reading == Dolgin E (September 2021). "The tangled history of mRNA vaccines" (PDF). Nature. 597 (9): 318–24. Bibcode:2021Natur.597..318D. doi:10.1038/d41586-021-02483-w. PMID 34522017. S2CID 237515383. Sahin U, Karikó K, Türeci Ö (October 2014). "mRNA-based therapeutics – developing a new class of drugs". Nat Rev Drug Discov. 13 (10): 759–80. doi:10.1038/nrd4278. PMID 25233993.
Novich, wrote: "Trainers of the old school who supplied treatments which had cocaine as their base declared with assurance that a rider tired by a six-day race would get his second breath after absorbing these mixtures." John Hoberman, a professor at the University of Texas in Austin, Texas, said six-day races were "de facto experiments investigating the physiology of stress as well as the substances that might alleviate exhaustion."
Sources: en.wikipedia.org
It is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, often abbreviated AEDG. The molecule is linear and contains no modified residues, so it is fully described by its sequence.
The compound came out of work on epithalamin, a peptide preparation derived from pineal tissue, conducted largely in Russian laboratories. Later studies in other countries examined it mainly in cell cultures and animal models.
The tetrapeptide sequence is a synthetic construct rather than a described circulating peptide. It was derived by analogy to peptide fractions obtained from tissue extracts, not isolated from blood or tissue as such.
It is a synthetic tetrapeptide. Its sequence was derived from research on peptide fractions of bovine pineal extract, and the intact AEDG sequence has not been demonstrated as an abundant free peptide in human tissue.